7 credits
0 h + 40.0 h
Q1
Teacher(s)
Delzenne Nathalie; des Rieux Anne; Feron Olivier; Gallez Bernard; Hermans Emmanuel coordinator; Leclercq Joëlle; Mingeot Marie-Paule; Muccioli Giulio; Vanbever Rita;
Language
French
Prerequisites
Professional integration activity
The prerequisite(s) for this Teaching Unit (Unité d’enseignement – UE) for the programmes/courses that offer this Teaching Unit are specified at the end of this sheet.
The prerequisite(s) for this Teaching Unit (Unité d’enseignement – UE) for the programmes/courses that offer this Teaching Unit are specified at the end of this sheet.
Main themes
Based on structure activity relationship, pharmacodynamy, toxicology, pharmacokinetic genomis and physicochemical properties of drugs, the student will integrate and discuss the different concepts and steps trading to the clinical testing of substances.
Aims
At the end of this learning unit, the student is able to : | |
1 | The aim of the seminars is to offer an integrated approach of basic concept in preclinical research (chemistry toxicology required to advance a substance to a drug in clinical trials. The approach developed in R&D departments in the pharmaceutical industry will be |
The contribution of this Teaching Unit to the development and command of the skills and learning outcomes of the programme(s) can be accessed at the end of this sheet, in the section entitled “Programmes/courses offering this Teaching Unit”.
Content
The student will do a personal work on the drug discovery process, biopharmaceutics, pharmacology and selection of dosage form for a target pathology and patient. Aspect needed for the file of marketing, authorisation will be required.
Other information
Prerequisite :
Pharmaceutical chemistry, pharmacology, pharmacokinetic, toxicology, pharmaceutical technology.
Evaluation:
Each subject will be presented orally
Faculty or entity
FARM